CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances

In the last decade, Chimeric Antigen Receptor (CAR)-T cell therapy has emerged as a promising immunotherapeutic approach to fight cancers. This approach consists of genetically engineered immune cells expressing a surface receptor, called CAR, that specifically targets antigens expressed on the surf...

Descripción completa

Detalles Bibliográficos
Autores principales: Maalej, Karama Makni, Merhi, Maysaloun, Inchakalody, Varghese P., Mestiri, Sarra, Alam, Majid, Maccalli, Cristina, Cherif, Honar, Uddin, Shahab, Steinhoff, Martin, Marincola, Francesco M., Dermime, Said
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885707/
https://www.ncbi.nlm.nih.gov/pubmed/36717905
http://dx.doi.org/10.1186/s12943-023-01723-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885707/
https://www.ncbi.nlm.nih.gov/pubmed/36717905
http://dx.doi.org/10.1186/s12943-023-01723-z

Ejemplares similares